Kebarle, 1993, Anal. Chem., 65, 972A, 10.1021/ac00070a001
Clarke, 1996, Pharm. Sci., 2, 203
Buhrman, 1996, J. Am. Soc. Mass Spectrom., 7, 1099, 10.1016/S1044-0305(96)00072-4
Matuszewski, 1998, Anal. Chem., 70, 882, 10.1021/ac971078+
Fu, 1998, J. Pharm. Biomed. Anal., 18, 347, 10.1016/S0731-7085(98)00048-X
Matuszewski, 2003, Anal. Chem., 75, 3019, 10.1021/ac020361s
Constanzer, 1997, J. Chromatogr. B, 693, 117, 10.1016/S0378-4347(97)00047-9
Matuszewski, 1998, J. Chromatogr. B, 716, 195, 10.1016/S0378-4347(98)00317-X
Jemal, 1999, Rapid Commun. Mass Spectrom., 13, 97, 10.1002/(SICI)1097-0231(19990130)13:2<97::AID-RCM461>3.0.CO;2-T
Food and Drug Administration, Guidance for Industry on Bioanalytical Method Validation, Federal Register, vol. 66, no. 100, 23 May 2001, p. 28526.
Shah, 2000, Pharm. Res., 17, 1551, 10.1023/A:1007669411738
Bonfiglio, 1999, Rapid Commun. Mass Spectrom., 13, 1175, 10.1002/(SICI)1097-0231(19990630)13:12<1175::AID-RCM639>3.0.CO;2-0
King, 2000, J. Am. Soc. Mass Spectrom., 11, 942, 10.1016/S1044-0305(00)00163-X
Choi, 2001, J. Chromatogr. A, 907, 337, 10.1016/S0021-9673(00)01052-9
Choi, 2001, Fresenius’ J. Anal. Chem., 369, 370, 10.1007/s002160000661
Avery, 2003, Rapid Commun. Mass Spectrom., 17, 197, 10.1002/rcm.895
Schuhmacher, 2003, Rapid Commun. Mass Spectrom., 17, 1950, 10.1002/rcm.1139
Sangster, 2004, Rapid Commun. Mass Spectrom., 18, 1361, 10.1002/rcm.1477
Chavez-Eng, 2002, J. Chromatogr. B, 767, 117, 10.1016/S0378-4347(01)00552-7
Kebarle, 2000, J. Mass Spectrom., 35, 804, 10.1002/1096-9888(200007)35:7<804::AID-JMS22>3.0.CO;2-Q
